$250 | Single User
$500 | Site License
$750 | Global License

Tasly Pharmaceutical Group Co Ltd (600535) - Medical Equipment - Deals and Alliances Profile [Report Updated: 27-09-2018]

Published by Global Data: 27 Sep 2018 | 223496 | In Stock

Introduction

Summary

Tasly Pharmaceutical Group Co Ltd (Tasly), formerly Tianjin Tasly Pharmaceutical Co., Ltd., manufactures and distributes chemical medicine, biological medicine, healthcare products, traditional Chinese medicine (TCM), functional food and other products. The company's product line includes herbal medicine, chemical medicine, health product, pharmaceutical substances and active pharmaceutical ingredients (APIs), herbal extract, tea, cosmetics, daily hygiene product series and medical equipment. It markets its products in domestic market through its own sales force and through distributors and subsidiaries in Malaysia, Indonesia, Vietnam, South Korea, Pakistan, Thailand, Istanbul, Botswana, South Africa, Ghana, Kenya, Zambia, Nigeria, Russia, Netherlands, Bahamas and the US. Tasly is headquartered in Tianjin, China.

Tasly Pharmaceutical Group Co Ltd (600535) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Tasly Pharmaceutical Group Co Ltd (600535) - Medical Equipment - Deals and Alliances Profile [Report Updated: 27-09-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

    Tasly Pharmaceutical Group Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

    Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

    Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

    Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

    Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deal Details 10

    Venture Financing 10

    Profusa Raises USD45 Million in Series C Venture Financing 10

    Shuwen Biotech Raises Funds in Series A+ Financing 11

    Equity Offering 12

    Tasly Pharma Plans Private Placement of Shares for up to USD406 Million 12

    Debt Offering 13

    Tasly Pharma Raises USD157 Million in Public Offering of 5.39% Notes Due 2021 13

    Tasly Pharma to Raise up to USD305.8 Million in Private Placement of Notes 14

    Tasly Pharma to Raise up to USD21.8 Million in Public Offering of Bonds 15

    Tasly Pharma Raises USD145.8 Million in Third Tranche of Public Offering of 3.16% Debentures 16

    Tasly Pharma Raises USD107.5 Million in Second Tranche of Public Offering of 3.17% Debentures 17

    Tasly Pharma Raises USD151.7 Million in First Tranche of Public Offering of 2.89% Debentures 18

    Tasly Pharma Raises USD195.8 Million in Public Offering of Bonds Due 2020 19

    Tasly Pharma Completes First Tranche Of Public Offering Of Bonds For US.7 Million 20

    Tasly Pharma Completes Public Offering Of Notes For US.6 Million 21

    Tianjin Tasly Pharma Completes Public Offering Of Notes Due 2013 For US.5 Million 22

    Acquisition 23

    Tasly Pharma To Acquire Additional 25% Stake In Pharma Packaging Technology Company 23

    Tasly Pharmaceutical Group Co Ltd - Key Competitors 24

    Tasly Pharmaceutical Group Co Ltd - Key Employees 25

    Tasly Pharmaceutical Group Co Ltd - Locations And Subsidiaries 26

    Head Office 26

    Other Locations & Subsidiaries 26

    Joint Venture 26

    Appendix 27

    Methodology 27

    About GlobalData 27

    Contact Us 27

    Disclaimer 27

List Of Tables
in Tasly Pharmaceutical Group Co Ltd (600535) - Medical Equipment - Deals and Alliances Profile [Report Updated: 27-09-2018]

List of Tables

Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Key Facts, 2017 2

Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Tasly Pharmaceutical Group Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Tasly Pharmaceutical Group Co Ltd, Deals By Market, 2012 to YTD 2018 8

Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Profusa Raises USD45 Million in Series C Venture Financing 10

Shuwen Biotech Raises Funds in Series A+ Financing 11

Tasly Pharma Plans Private Placement of Shares for up to USD406 Million 12

Tasly Pharma Raises USD157 Million in Public Offering of 5.39% Notes Due 2021 13

Tasly Pharma to Raise up to USD305.8 Million in Private Placement of Notes 14

Tasly Pharma to Raise up to USD21.8 Million in Public Offering of Bonds 15

Tasly Pharma Raises USD145.8 Million in Third Tranche of Public Offering of 3.16% Debentures 16

Tasly Pharma Raises USD107.5 Million in Second Tranche of Public Offering of 3.17% Debentures 17

Tasly Pharma Raises USD151.7 Million in First Tranche of Public Offering of 2.89% Debentures 18

Tasly Pharma Raises USD195.8 Million in Public Offering of Bonds Due 2020 19

Tasly Pharma Completes First Tranche Of Public Offering Of Bonds For US.7 Million 20

Tasly Pharma Completes Public Offering Of Notes For US.6 Million 21

Tianjin Tasly Pharma Completes Public Offering Of Notes Due 2013 For US.5 Million 22

Tasly Pharma To Acquire Additional 25% Stake In Pharma Packaging Technology Company 23

Tasly Pharmaceutical Group Co Ltd, Key Competitors 24

Tasly Pharmaceutical Group Co Ltd, Key Employees 25

Tasly Pharmaceutical Group Co Ltd, Subsidiaries 26

Tasly Pharmaceutical Group Co Ltd, Joint Venture 26

List Of Figures, Charts and Diagrams
in Tasly Pharmaceutical Group Co Ltd (600535) - Medical Equipment - Deals and Alliances Profile [Report Updated: 27-09-2018]

List of Figures

Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Tasly Pharmaceutical Group Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

Additional Details

Publisher

Global Data

Publisher Information

Reference

223496 | GDME139197D

Number of Pages

27

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Tasly Pharmaceutical Group Co Ltd (600535) - Medical Equipment - Deals and Alliances Profile
SummaryTasly Pharmaceutical Group Co Ltd (Tasly), formerly Tianjin Tasly Pharmaceutical Co., Ltd., i...
14 Feb 2017 by Global Data USD $250 More Info
Tasly Pharmaceutical Group Co Ltd (600535) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryTasly Pharmaceutical Group Co Ltd (Tasly), formerly Tianjin Tasly Pharmaceutical Co., Ltd., i...
28 Nov 2016 by Global Data USD $250 More Info
Tasly Pharmaceutical Group Co., Ltd. (600535) - Medical Equipment - Deals and Alliances Profile
SummaryTasly Pharmaceutical Group Co Ltd (Tasly), formerly Tianjin Tasly Pharmaceutical Co., Ltd., i...
14 Nov 2016 by Global Data USD $250 More Info
Tasly Pharmaceutical Group Co., Ltd. (600535) - Financial and Strategic SWOT Analysis Review
Tasly Pharmaceutical Group Co., Ltd. (600535) - Financial and Strategic SWOT Analysis Review provide...
17 Aug 2016 by Global Data USD $125 More Info
Tasly Pharmaceutical Group Co., Ltd. (600535) - Medical Equipment - Deals and Alliances Profile
SummaryTasly Pharmaceutical Group Co., Ltd. (Tasly), formerly Tianjin Tasly Pharmaceutical Co., Ltd....
28 Jul 2016 by Global Data USD $250 More Info
Tasly Pharmaceutical Group Co., Ltd. (600535) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryTasly Pharmaceutical Group Co., Ltd. (Tasly), formerly Tianjin Tasly Pharmaceutical Co., Ltd....
10 May 2016 by Global Data USD $250 More Info
Tasly Pharmaceutical Group Co., Ltd. (formerly Tianjin Tasly Pharmaceutical Co., Ltd.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r...
15 Apr 2016 by Marketline USD $350 More Info
Tasly Pharmaceutical Group Co., Ltd. (600535) - Medical Equipment - Deals and Alliances Profile
SummaryTasly Pharmaceutical Group Co., Ltd. (Tasly), formerly Tianjin Tasly Pharmaceutical Co., Ltd....
14 Apr 2016 by Global Data USD $250 More Info
Tasly Pharmaceutical Group Co., Ltd. (600535) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryTasly Pharmaceutical Group Co., Ltd. (Tasly), formerly Tianjin Tasly Pharmaceutical Co., Ltd....
09 Mar 2016 by Global Data USD $250 More Info
Tasly Pharmaceutical Group Co., Ltd. (600535) - Medical Equipment - Deals and Alliances Profile
SummaryTasly Pharmaceutical Group Co., Ltd. (Tasly), formerly Tianjin Tasly Pharmaceutical Co., Ltd....
24 Feb 2016 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Tasly Pharmaceutical Group Co Ltd (600535) - Medical Equipment - Deals and Alliances Profile [Report Updated: 27-09-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data